Royal DSM to continue investing in Jingjiang

Royal DSM, a Dutch company specializing in solutions for nutrition, health and sustainable living, has pledged to continue investing in Jingjiang, a city in East China's Jiangsu province.

This was announced by the president of DSM-Firmenich Global Strategic Partnership M&A, Michael Wahl, during an exchange meeting in Jingjiang on June 13.

Michael Wahl, president of DSM-Firmenich Global Strategic Partnership M&A, holds talks in Jingjiang city. [Photo/zhjjwx.jsjjw.cn]

Royal DSM had previously acquired Jingjiang-based Jiangsu Jiangshan Pharmaceutical Co Ltd in 2015 and renamed it DSM Jiangshan Pharmaceutical (Jiangsu) Co Ltd.

Wahl expressed gratitude to the Jingjiang municipal government for its long-term support of DSM Jiangshan Pharmaceutical (Jiangsu) Co Ltd. He said that Jingjiang's achievements in the integration of port, industry, and city, industrial planning, and business environment creation are impressive.

Wahl said that Jingjiang's future plans for industrial development in the health sector are progressive.

He added that DSM-Firmenich is willing to participate in the future industrial development of Jingjiang, and to develop deeper and broader cooperation prospects.

He hopes that the municipal government of Jingjiang will continue to care about and support enterprises and that it will create a good environment for their development.

Royal DSM recently completed a merger with global essence-making company Firmenich to create a new company focused on nutrition, health, and beauty. It has operations in nearly 60 countries and revenue streams reaching more than 12 billion euros ($13.01 billion).